The Treatment of Relapsed or Refractory Intermediate Grade Non-Hodgkin’s Lymphoma With Autologous Bone Marrow Transplantation Followed by Cyclosporine and Interferon

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1700646
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Complex Partial Status Epilepticus After Bone Marrow Transplantation for Non-Hodgkin’s Lymphoma

Bone Marrow Transplantation
TransplantationHematology
1997English

Targeted Drug Brentuximab Vedotin for Treatment of Relapsed or Refractory Cd30-Positive Hodgkin’s Lymphoma

Malignant tumours
2017English

Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Frequency of Lymphomatous Infiltration of Hodgkin’s & Non-Hodgkin’s Lymphoma in Bone Marrow by Bone Marrow Aspiration, Trephine Biopsy and Clot Section

Annals of International medical and Dental Research
2018English

rhTPO Combined With Chemotherapy and G-CSF for Autologous Peripheral Blood Stem Cells in Patients With Refractory/Relapsed Non-Hodgkin’s Lymphoma

Cancer Management and Research
Oncology
2019English

Prolonged Remission of Longstanding Systemic Lupus Erythematosus After Autologous Bone Marrow Transplant for Non-Hodgkin’s Lymphoma

Bone Marrow Transplantation
TransplantationHematology
1997English

Clinical Characteristics and Treatment Results of Pediatric Relapsed/Refractory Non-Hodgkin’s Lymphomas

Oncogematologiya
OncologyHematology
2018English

Outcomes of Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory HIV-associated Lymphoma

Bone Marrow Transplantation
TransplantationHematology
2016English

Copanlisib Treatment of Patients With Relapsed or Refractory Marginal Zone Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy